Speaker

Michelene Taptich

Vice President, Commercial Accounting, Priovant Therapeutics

Michelene Taptich, Vice President, Commercial Accounting at Priovant Therapeutics, spoke at Finance & Accounting for Bioscience (Boston, United States of America, 24–25 Sept 2026) in the session “Optimizing ERP Systems: Tools and Strategies for Biotech Growth”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

Finance & Accounting for Bioscience
24–25 Sept 2026Boston, United States of America
- PlenaryOptimizing ERP Systems: Tools and Strategies for Biotech GrowthWith Kyle Mandala, Maggie Berkeley, Gina Tracey

More speakers at Finance & Accounting for Bioscience

Maricel Apuli
Chief Accounting Officer, BridgeBio
Juan Betanzo
Vice President, Strategic Finance, EyePoint
Kwame Boateng
Independent
Kathleen Borthwick
Chief Financial Officer, Passage Bio
Melissa Bradford-Klug
Chief Financial & Business Officer, NorthSea Therapeutics
Jen Cadigan
Partner & Life Sciences Lead, CrossCountry Consulting

See all 38 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Michelene Taptich, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].